KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients

Autor: Vivi M. Heine, Joan Torrella Barrufet, Lisa Hinz

Publikováno v: Hinz, L, Torrella Barrufet, J & Heine, V M 2019, ' KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients ', Acta Neuropathologica Communications, vol. 7, no. 1, 196 . https://doi.org/10.1186/s40478-019-0852-x
Acta Neuropathologica Communications
Acta neuropathologica communications, 7(1):196. BioMed Central
Hinz, L, Torrella Barrufet, J & Heine, V M 2019, ' KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients ', Acta neuropathologica communications, vol. 7, no. 1, 196 . https://doi.org/10.1186/s40478-019-0852-x
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-6 (2019)
Acta Neuropathologica Communications, 7(1):196. BioMed Central

Rett Syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the Methyl CpG binding protein 2 (MECP2) gene. Deficient K+-Cl—co-transporter 2 (KCC2) expression is suggested to play a key role in the neurodevelopmental delay in RTT pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81333fe2802ffb83eec8a68a49df1821
https://research.vu.nl/en/publications/7cc69739-b413-4aee-8402-36b2ed158e2f